Thyroid Associated Ophthalmopathies Clinical Trials
3 recruiting trials for Thyroid Associated Ophthalmopathies. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
1
Sponsors
Recruiting Trials
RECRUITINGPhase 4NCT07152340
The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO...
Thyroid-associated ophthalmopathy (TAO) is an organ-specific autoimmune disease closely related to thyroid disease, which leads the incidence of orbital disease in adults and is...
Sponsor: Shanghai Changzheng HospitalEnrolling: 642 locations
RECRUITINGPhase 4NCT07152392
Evaluation of the Efficacy and Safety Observation of IBI311 Treatment in Patients With Inactive TAO
Thyroid-associated ophthalmopathy (TAO) is an organ-specific autoimmune disease closely related to thyroid disease, which leads the incidence of orbital disease in adults and is...
Sponsor: Shanghai Changzheng HospitalEnrolling: 501 location
RECRUITINGPhase 4NCT07152366
Efficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With Moderate to Severe TAO in the...
Thyroid-associated ophthalmopathy (TAO) is an organ-specific autoimmune disease closely related to thyroid disease, which leads the incidence of orbital disease in adults and is...
Sponsor: Shanghai Changzheng HospitalEnrolling: 961 location